STOCK TITAN

MRMD Form 4: CFO Mario Pinho Vesting and Tax-Withholding Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Mario Pinho, Chief Financial Officer of Marimed Inc. (MRMD), reported transactions dated 09/15/2025. The filing shows 16,076 restricted stock units (RSUs) treated as acquired and convertible one-for-one into common shares, and 4,574 shares withheld to satisfy tax withholding at a reported price of $0.1374 per share. Following the reported activity the filing lists 157,386 shares beneficially owned directly by the reporting person. The RSUs were originally granted May 9, 2025, and remaining RSUs vest on December 15, 2025, under the award agreement. The Form 4 was signed 09/16/2025.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine insider vesting and tax-withholding; minor share movement with no revenue or debt implications.

The Form 4 documents a standard executive equity vesting event: 16,076 RSUs converted on 09/15/2025 and 4,574 shares withheld to meet tax obligations at $0.1374 per share. The net change reduces outstanding shares held by the insider modestly but does not indicate open-market purchases or sales beyond withholding. This is an expected compensation-related transaction and should be viewed as operational equity management rather than a signal of company-wide material change.

TL;DR: Compensation vesting followed award terms; disclosure aligns with Section 16 requirements.

The report discloses that RSUs granted May 9, 2025, vested in part on 09/15/2025 with remaining RSUs scheduled to vest December 15, 2025, consistent with award agreement timing. The withholding of 4,574 shares for taxes is a common practice to satisfy tax withholding obligations. The filing appears complete for the disclosed transactions and was timely signed on 09/16/2025, meeting routine compliance expectations.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Pinho Mario

(Last) (First) (Middle)
C/O MARIMED INC.
10 OCEANA WAY

(Street)
NORWOOD MA 02062

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock 09/15/2025 M 16,076 A $0(1) 161,960 D
Common stock 09/15/2025 F 4,574(2) D $0.1374 157,386 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (RSU) (1) 09/15/2025 M 16,076 (3) (3) Common Stock, par value $.001 per share 16,076 $0 16,075 D
Explanation of Responses:
1. RSUs convert to shares of common stock on a one-for-one basis.
2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
3. The RSUs were granted on May 9, 2025; the remaining RSUs will vest on December 15, 2025 in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
Remarks:
/s/ Mario Pinho 09/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did MRMD insider Mario Pinho report on Form 4?

Answer: The Form 4 reports conversion/vesting of 16,076 RSUs and withholding of 4,574 shares for taxes, both dated 09/15/2025.

How many shares does Mario Pinho beneficially own after the reported transactions?

Answer: The filing lists 157,386 shares beneficially owned following the reported transactions.

When were the RSUs granted and when do remaining RSUs vest?

Answer: The RSUs were granted on May 9, 2025; remaining RSUs will vest on December 15, 2025 per the award agreement.

What was the price reported for the shares withheld for taxes?

Answer: The shares withheld are reported with a price of $0.1374 per share.

What disclosure role and filing date are shown on the Form 4?

Answer: Mario Pinho is reported as Chief Financial Officer and the Form 4 was signed on 09/16/2025.
Marimed

OTC:MRMD

MRMD Rankings

MRMD Latest News

MRMD Latest SEC Filings

MRMD Stock Data

56.49M
280.32M
14.7%
0.24%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Norwood